National Institute on Drug Abuse symposium report: Drugs of abuse, dopamine, and HIV-associated neurocognitive disorders/HIV-associated dementia

Journal of NeuroVirology

Volumn 19, Issue 2, 2013, Pages 119-122

  Purohit, Vishnudutt ^a   Rapaka, Rao ^a   Frankenheim, Jerry ^a   Avila, Albert ^a   Sorensen, Roger ^a   Rutter, Joni ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Dopamine; Drugs of abuse; HAD; HAND; HIV

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; COCAINE; DOPAMINE; DOPAMINE RECEPTOR; DOPAMINE TRANSPORTER; HUMAN IMMUNODEFICIENCY VIRUS PROTEIN; METHAMPHETAMINE; VIRUS RNA;

DOPAMINE BRAIN LEVEL; DOPAMINE METABOLISM; DRUG ABUSE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LIPID PEROXIDATION; NONHUMAN; PRIORITY JOURNAL; PUTAMEN; REVIEW; SUBSTANTIA NIGRA; VIRUS LOAD;

AIDS DEMENTIA COMPLEX; BRAIN; COGNITION; DOPAMINE; HIV-1; HUMANS; NATIONAL INSTITUTE ON DRUG ABUSE (U.S.); STREET DRUGS; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

EID: 84882727202     PISSN: 13550284     EISSN: 15382443     Source Type: Journal    
DOI: 10.1007/s13365-013-0153-2     Document Type: Review

References (15)

1. Chang L, Wang GJ, Volkow ND, Ernst T, Telang F, Logan J, Fowler JS (2008) Decreased brain dopamine transporters are related to cognitive deficits in HIV patients with or without cocaine abuse. NeuroImage 42:869-878
2. Czub S, Koutsilieri E, Sopper S, Czub M, Stahl-Hennig C, Müller JG, Pedersen V, Gsell W, Heeney JL, Gerlach M, Gosztonyi G, Riederer P, ter Meulen V (2001) Enhancement of central nervous system pathology in early simian immunodeficiency virus infection by dopaminergic drugs. Acta Neuropathol 101:85-91
3. Czub S, Czub M, Koutsilieri E, Sopper S, Villinger F, Müller JG, Stahl-Hennig C, Riederer P, Ter Meulen V, Gosztonyi G (2004) Modulation of Simian immunodeficiency virus neuropathology by dopaminergic drugs. Acta Neuropathol 107:216-226
4. Gaskill PJ, Calderon TM, Luers AJ, Eugenin EA, Javitch JA, Berman JW (2009) Human immunodeficiency virus (HIV) infection of human macrophages is increased by dopamine: a bridge between HIV-associated neurologic disorders and drug abuse. Am J Pathol 175:1148-1159
5. Gaskill PJ, Carvallo L, Eugenin EA, Berman JW (2012) Characterization and function of the human macrophage dopaminergic system: implications for CNS disease and drug abuse. J Neuroinflammation 9:203. doi: 10.1186/1742-2094-9-203
6. Krasnova IN, Cadet JL (2009) Methamphetamine toxicity and messengers of death. Brain Res Rev 60:379-407
7. Kuhn DM, Francescutti-Verbeem DM, Thomas DM (2006) Dopamine quinones activate microglia and induce a neurotoxic gene expression profile: relationship to methamphetamine-induced nerve ending damage. Ann N YAcad Sci 1074:31-41
8. Kumar AM, Borodowsky I, Fernandez B, Gonzalez L, Kumar M (2007) Human immunodeficiency virus type 1 RNA Levels in different regions of human brain: quantification using real-time reverse transcriptase-polymerase chain reaction. J Neurovirol 13:210-224
9. Kumar AM, Fernandez JB, Singer EJ, Commins D, Waldrop-Valverde D, Ownby RL, Kumar M (2009) Human immunodeficiency virus type 1 in the central nervous system leads to decreased dopamine in different regions of postmortem human brains. J Neurovirol 15:257-274
10. Nair MP, Mahajan S, Sykes D, Bapardekar MV, Reynolds JL (2006) Methamphetamine modulates DC-SIGN expression by mature dendritic cells. J Neuroimmune Pharmacol 1:296-304
11. Nair MP, Saiyed ZM, Nair N, Gandhi NH, Rodriguez JW, Boukli N, Provencio-Vasquez E, Malow RM, Miguez-Burbano MJ (2009) Methamphetamine enhances HIV-1 infectivity in monocyte derived dendritic cells. J Neuroimmune Pharmacol 4:129-139
12. Pedrosa R, Soares-da-Silva P (2002) Oxidative and non-oxidative mechanisms of neuronal cell death and apoptosis by l-3,4-dihydroxyphenylalanine (l-DOPA) and dopamine. Br J Pharmacol 137:1305-1313
13. Purohit V, Rapaka R, Shurtleff D (2011) Drugs of abuse, dopamine, and HIV-associated neurocognitive disorders/HIV-associated dementia. Mol Neurobiol 44:102-110
14. Scheller C, Sopper S, Jassoy C, ter Meulen V, Riederer P, Koutsilieri E (2000) Dopamine activates HIV in chronically infected T lymphoblasts. J Neural Transm 107:1483-1489
15. Wang GJ, Chang L, Volkow ND, Telang F, Logan J, Ernst T, Fowler JS (2004) Decreased brain dopaminergic transporters in HIV-associated dementia patients. Brain 127:2452-2458